The emerging treatment of this peptide represents a major advance in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide150783.designertoblog.com/73490112/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment